nodes	percent_of_prediction	percent_of_DWPC	metapath
Telaprevir—CYP3A4—Thiotepa—sarcoma	0.0776	0.202	CbGbCtD
Telaprevir—ABCB1—Dactinomycin—sarcoma	0.0622	0.162	CbGbCtD
Telaprevir—Urate nephropathy—Vincristine—sarcoma	0.0597	0.26	CcSEcCtD
Telaprevir—ABCB1—Mitoxantrone—sarcoma	0.0557	0.145	CbGbCtD
Telaprevir—ABCB1—Vincristine—sarcoma	0.0383	0.0996	CbGbCtD
Telaprevir—ABCB1—Etoposide—sarcoma	0.0351	0.0913	CbGbCtD
Telaprevir—CYP3A4—Mitoxantrone—sarcoma	0.0334	0.0867	CbGbCtD
Telaprevir—ABCB1—Doxorubicin—sarcoma	0.0239	0.0623	CbGbCtD
Telaprevir—CYP3A4—Vincristine—sarcoma	0.023	0.0597	CbGbCtD
Telaprevir—CYP3A4—Etoposide—sarcoma	0.021	0.0547	CbGbCtD
Telaprevir—CTSK—periosteum—sarcoma	0.0201	0.0805	CbGeAlD
Telaprevir—CTSK—skull—sarcoma	0.0165	0.0661	CbGeAlD
Telaprevir—CTSK—leg—sarcoma	0.016	0.0642	CbGeAlD
Telaprevir—CTSK—forelimb—sarcoma	0.0159	0.0637	CbGeAlD
Telaprevir—CYP3A4—Doxorubicin—sarcoma	0.0143	0.0373	CbGbCtD
Telaprevir—CTSK—hindlimb—sarcoma	0.0143	0.0573	CbGeAlD
Telaprevir—CTSK—cartilage tissue—sarcoma	0.0141	0.0564	CbGeAlD
Telaprevir—CTSK—appendage—sarcoma	0.0123	0.0492	CbGeAlD
Telaprevir—CMA1—Activation of Matrix Metalloproteinases—COL18A1—sarcoma	0.0105	0.0772	CbGpPWpGaD
Telaprevir—Proctitis—Dactinomycin—sarcoma	0.00948	0.0413	CcSEcCtD
Telaprevir—CELA1—skin of body—sarcoma	0.00941	0.0378	CbGeAlD
Telaprevir—CTSK—Activation of Matrix Metalloproteinases—COL18A1—sarcoma	0.00939	0.0688	CbGpPWpGaD
Telaprevir—CTSK—Collagen degradation—COL18A1—sarcoma	0.00818	0.0599	CbGpPWpGaD
Telaprevir—CTSK—mammary gland—sarcoma	0.00596	0.0239	CbGeAlD
Telaprevir—CMA1—hematopoietic system—sarcoma	0.00564	0.0226	CbGeAlD
Telaprevir—CMA1—connective tissue—sarcoma	0.00543	0.0218	CbGeAlD
Telaprevir—CTSS—Assembly of collagen fibrils and other multimeric structures—COL18A1—sarcoma	0.00524	0.0384	CbGpPWpGaD
Telaprevir—CMA1—smooth muscle tissue—sarcoma	0.00497	0.0199	CbGeAlD
Telaprevir—CMA1—skin of body—sarcoma	0.0049	0.0197	CbGeAlD
Telaprevir—CTSK—RANKL/RANK Signaling Pathway—MITF—sarcoma	0.00476	0.0349	CbGpPWpGaD
Telaprevir—CMA1—Degradation of the extracellular matrix—COL18A1—sarcoma	0.00465	0.034	CbGpPWpGaD
Telaprevir—CTSK—myometrium—sarcoma	0.00423	0.017	CbGeAlD
Telaprevir—CTSK—Degradation of the extracellular matrix—COL18A1—sarcoma	0.00414	0.0303	CbGpPWpGaD
Telaprevir—CMA1—lymphoid tissue—sarcoma	0.00397	0.0159	CbGeAlD
Telaprevir—Proctitis—Epirubicin—sarcoma	0.00384	0.0167	CcSEcCtD
Telaprevir—CTSK—seminal vesicle—sarcoma	0.00382	0.0153	CbGeAlD
Telaprevir—CTSS—myometrium—sarcoma	0.00371	0.0149	CbGeAlD
Telaprevir—CTSK—hematopoietic system—sarcoma	0.00363	0.0146	CbGeAlD
Telaprevir—Hypothyroidism—Thiotepa—sarcoma	0.00363	0.0158	CcSEcCtD
Telaprevir—CTSK—RANKL/RANK Signaling Pathway—PLCG1—sarcoma	0.00362	0.0266	CbGpPWpGaD
Telaprevir—CMA1—bone marrow—sarcoma	0.00361	0.0145	CbGeAlD
Telaprevir—CTSS—Collagen formation—COL18A1—sarcoma	0.00357	0.0262	CbGpPWpGaD
Telaprevir—CTSS—embryo—sarcoma	0.00357	0.0143	CbGeAlD
Telaprevir—Proctitis—Doxorubicin—sarcoma	0.00356	0.0155	CcSEcCtD
Telaprevir—CTSK—connective tissue—sarcoma	0.0035	0.014	CbGeAlD
Telaprevir—CTSS—Degradation of the extracellular matrix—COL18A1—sarcoma	0.00341	0.025	CbGpPWpGaD
Telaprevir—CTSS—seminal vesicle—sarcoma	0.00335	0.0134	CbGeAlD
Telaprevir—CTSK—smooth muscle tissue—sarcoma	0.0032	0.0128	CbGeAlD
Telaprevir—CTSS—hematopoietic system—sarcoma	0.00318	0.0128	CbGeAlD
Telaprevir—CTSK—skin of body—sarcoma	0.00316	0.0127	CbGeAlD
Telaprevir—CTSS—connective tissue—sarcoma	0.00306	0.0123	CbGeAlD
Telaprevir—Anorectal discomfort—Etoposide—sarcoma	0.00306	0.0133	CcSEcCtD
Telaprevir—CMA1—Activation of Matrix Metalloproteinases—MMP2—sarcoma	0.00301	0.022	CbGpPWpGaD
Telaprevir—CMA1—liver—sarcoma	0.00292	0.0117	CbGeAlD
Telaprevir—Endocrine disorder—Thiotepa—sarcoma	0.00281	0.0122	CcSEcCtD
Telaprevir—CTSS—smooth muscle tissue—sarcoma	0.0028	0.0112	CbGeAlD
Telaprevir—CTSS—skin of body—sarcoma	0.00277	0.0111	CbGeAlD
Telaprevir—CTSK—cardiac atrium—sarcoma	0.00276	0.0111	CbGeAlD
Telaprevir—CTSK—uterus—sarcoma	0.00274	0.011	CbGeAlD
Telaprevir—ALB—mammary gland—sarcoma	0.00274	0.011	CbGeAlD
Telaprevir—CTSK—Activation of Matrix Metalloproteinases—MMP2—sarcoma	0.00268	0.0196	CbGpPWpGaD
Telaprevir—Hyperbilirubinaemia—Thiotepa—sarcoma	0.00256	0.0112	CcSEcCtD
Telaprevir—CTSK—lymphoid tissue—sarcoma	0.00256	0.0103	CbGeAlD
Telaprevir—Hyperuricaemia—Thiotepa—sarcoma	0.00251	0.0109	CcSEcCtD
Telaprevir—CTSS—uterus—sarcoma	0.0024	0.00964	CbGeAlD
Telaprevir—CTSK—tendon—sarcoma	0.0024	0.00964	CbGeAlD
Telaprevir—Blood uric acid increased—Thiotepa—sarcoma	0.00237	0.0103	CcSEcCtD
Telaprevir—CTSK—Collagen degradation—MMP2—sarcoma	0.00233	0.0171	CbGpPWpGaD
Telaprevir—CTSK—bone marrow—sarcoma	0.00233	0.00934	CbGeAlD
Telaprevir—CTSS—lymphoid tissue—sarcoma	0.00224	0.00899	CbGeAlD
Telaprevir—CMA1—lymph node—sarcoma	0.00224	0.00898	CbGeAlD
Telaprevir—Hyperuricaemia—Vincristine—sarcoma	0.00223	0.0097	CcSEcCtD
Telaprevir—Hyperuricaemia—Mitoxantrone—sarcoma	0.00217	0.00945	CcSEcCtD
Telaprevir—CTSS—tendon—sarcoma	0.00211	0.00845	CbGeAlD
Telaprevir—Blood uric acid increased—Vincristine—sarcoma	0.0021	0.00917	CcSEcCtD
Telaprevir—ALB—Scavenging of heme from plasma—HBA1—sarcoma	0.00209	0.0153	CbGpPWpGaD
Telaprevir—Blood uric acid increased—Mitoxantrone—sarcoma	0.00205	0.00893	CcSEcCtD
Telaprevir—CTSS—bone marrow—sarcoma	0.00204	0.00819	CbGeAlD
Telaprevir—Proctalgia—Epirubicin—sarcoma	0.002	0.00872	CcSEcCtD
Telaprevir—CTSK—testis—sarcoma	0.00199	0.00799	CbGeAlD
Telaprevir—CMA1—Extracellular matrix organization—COL18A1—sarcoma	0.00195	0.0143	CbGpPWpGaD
Telaprevir—ORM1—hematopoietic system—sarcoma	0.0019	0.00762	CbGeAlD
Telaprevir—CTSK—liver—sarcoma	0.00188	0.00755	CbGeAlD
Telaprevir—Proctalgia—Doxorubicin—sarcoma	0.00185	0.00807	CcSEcCtD
Telaprevir—Lymphopenia—Epirubicin—sarcoma	0.00183	0.00799	CcSEcCtD
Telaprevir—Hyperuricaemia—Etoposide—sarcoma	0.0018	0.00786	CcSEcCtD
Telaprevir—CTSS—testis—sarcoma	0.00174	0.007	CbGeAlD
Telaprevir—CTSK—Extracellular matrix organization—COL18A1—sarcoma	0.00174	0.0127	CbGpPWpGaD
Telaprevir—Anorectal discomfort—Epirubicin—sarcoma	0.00172	0.00748	CcSEcCtD
Telaprevir—Blood uric acid increased—Etoposide—sarcoma	0.00171	0.00743	CcSEcCtD
Telaprevir—Lymphopenia—Doxorubicin—sarcoma	0.0017	0.00739	CcSEcCtD
Telaprevir—CTSS—liver—sarcoma	0.00165	0.00661	CbGeAlD
Telaprevir—CTSK—Toll-Like Receptors Cascades—ATF1—sarcoma	0.00162	0.0119	CbGpPWpGaD
Telaprevir—Candida infection—Etoposide—sarcoma	0.0016	0.00696	CcSEcCtD
Telaprevir—Anorectal discomfort—Doxorubicin—sarcoma	0.00159	0.00692	CcSEcCtD
Telaprevir—Blood creatinine increased—Thiotepa—sarcoma	0.00159	0.0069	CcSEcCtD
Telaprevir—Renal failure acute—Mitoxantrone—sarcoma	0.00158	0.00689	CcSEcCtD
Telaprevir—Toxic epidermal necrolysis—Dactinomycin—sarcoma	0.00151	0.00659	CcSEcCtD
Telaprevir—Oral candidiasis—Epirubicin—sarcoma	0.00148	0.00643	CcSEcCtD
Telaprevir—CTSK—lymph node—sarcoma	0.00144	0.00579	CbGeAlD
Telaprevir—CTSS—Extracellular matrix organization—COL18A1—sarcoma	0.00143	0.0105	CbGpPWpGaD
Telaprevir—Blood creatinine increased—Mitoxantrone—sarcoma	0.00137	0.00596	CcSEcCtD
Telaprevir—Oral candidiasis—Doxorubicin—sarcoma	0.00137	0.00595	CcSEcCtD
Telaprevir—CMA1—Signaling by SCF-KIT—FOXO1—sarcoma	0.00136	0.00995	CbGpPWpGaD
Telaprevir—CMA1—Signaling by SCF-KIT—PDGFRB—sarcoma	0.00136	0.00994	CbGpPWpGaD
Telaprevir—CTSK—RANKL/RANK Signaling Pathway—JUN—sarcoma	0.00134	0.00983	CbGpPWpGaD
Telaprevir—CMA1—Signaling by SCF-KIT—PDGFRA—sarcoma	0.00134	0.00978	CbGpPWpGaD
Telaprevir—CTSS—Toll-Like Receptors Cascades—ATF1—sarcoma	0.00134	0.00978	CbGpPWpGaD
Telaprevir—Hypokalaemia—Mitoxantrone—sarcoma	0.00133	0.00579	CcSEcCtD
Telaprevir—CMA1—Degradation of the extracellular matrix—MMP2—sarcoma	0.00133	0.00971	CbGpPWpGaD
Telaprevir—Infestation—Thiotepa—sarcoma	0.0013	0.00568	CcSEcCtD
Telaprevir—Infestation NOS—Thiotepa—sarcoma	0.0013	0.00568	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Dactinomycin—sarcoma	0.00128	0.00559	CcSEcCtD
Telaprevir—CTSS—lymph node—sarcoma	0.00126	0.00507	CbGeAlD
Telaprevir—Hepatobiliary disease—Thiotepa—sarcoma	0.00123	0.00537	CcSEcCtD
Telaprevir—ORM1—bone marrow—sarcoma	0.00122	0.00489	CbGeAlD
Telaprevir—CTSK—RANKL/RANK Signaling Pathway—SRC—sarcoma	0.0012	0.00881	CbGpPWpGaD
Telaprevir—CTSK—Degradation of the extracellular matrix—MMP2—sarcoma	0.00118	0.00866	CbGpPWpGaD
Telaprevir—Urinary tract disorder—Thiotepa—sarcoma	0.00116	0.00503	CcSEcCtD
Telaprevir—Urethral disorder—Thiotepa—sarcoma	0.00115	0.005	CcSEcCtD
Telaprevir—Erythema multiforme—Dactinomycin—sarcoma	0.0011	0.00478	CcSEcCtD
Telaprevir—Toxic epidermal necrolysis—Etoposide—sarcoma	0.00109	0.00477	CcSEcCtD
Telaprevir—Eye disorder—Thiotepa—sarcoma	0.00109	0.00476	CcSEcCtD
Telaprevir—CMA1—Peptide hormone metabolism—CTNNB1—sarcoma	0.00105	0.00772	CbGpPWpGaD
Telaprevir—Rectal haemorrhage—Epirubicin—sarcoma	0.00104	0.00453	CcSEcCtD
Telaprevir—CMA1—Signaling by SCF-KIT—KIT—sarcoma	0.00104	0.00758	CbGpPWpGaD
Telaprevir—Hyperbilirubinaemia—Epirubicin—sarcoma	0.00103	0.0045	CcSEcCtD
Telaprevir—Urinary tract disorder—Vincristine—sarcoma	0.00103	0.00446	CcSEcCtD
Telaprevir—Malnutrition—Thiotepa—sarcoma	0.00102	0.00444	CcSEcCtD
Telaprevir—Urethral disorder—Vincristine—sarcoma	0.00102	0.00443	CcSEcCtD
Telaprevir—Hyperuricaemia—Epirubicin—sarcoma	0.00101	0.00441	CcSEcCtD
Telaprevir—CMA1—Signaling by SCF-KIT—CREB1—sarcoma	0.000986	0.00722	CbGpPWpGaD
Telaprevir—ORM1—liver—sarcoma	0.000985	0.00395	CbGeAlD
Telaprevir—CTSS—Degradation of the extracellular matrix—MMP2—sarcoma	0.000973	0.00713	CbGpPWpGaD
Telaprevir—Rectal haemorrhage—Doxorubicin—sarcoma	0.000961	0.00419	CcSEcCtD
Telaprevir—Blood uric acid increased—Epirubicin—sarcoma	0.000956	0.00416	CcSEcCtD
Telaprevir—Hyperbilirubinaemia—Doxorubicin—sarcoma	0.000955	0.00416	CcSEcCtD
Telaprevir—Anaemia—Thiotepa—sarcoma	0.000942	0.0041	CcSEcCtD
Telaprevir—Infestation NOS—Etoposide—sarcoma	0.000937	0.00408	CcSEcCtD
Telaprevir—Infestation—Etoposide—sarcoma	0.000937	0.00408	CcSEcCtD
Telaprevir—Hyperuricaemia—Doxorubicin—sarcoma	0.000936	0.00408	CcSEcCtD
Telaprevir—Anaemia—Dactinomycin—sarcoma	0.000935	0.00407	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Etoposide—sarcoma	0.000929	0.00404	CcSEcCtD
Telaprevir—ALB—testis—sarcoma	0.000913	0.00366	CbGeAlD
Telaprevir—Candida infection—Epirubicin—sarcoma	0.000896	0.0039	CcSEcCtD
Telaprevir—Hepatobiliary disease—Etoposide—sarcoma	0.000886	0.00386	CcSEcCtD
Telaprevir—Blood uric acid increased—Doxorubicin—sarcoma	0.000884	0.00385	CcSEcCtD
Telaprevir—CTSK—Toll-Like Receptors Cascades—CREB1—sarcoma	0.000878	0.00643	CbGpPWpGaD
Telaprevir—ALB—liver—sarcoma	0.000863	0.00346	CbGeAlD
Telaprevir—Dysgeusia—Mitoxantrone—sarcoma	0.000862	0.00375	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.000862	0.00375	CcSEcCtD
Telaprevir—Anaemia—Vincristine—sarcoma	0.000835	0.00364	CcSEcCtD
Telaprevir—ALB—Binding and Uptake of Ligands by Scavenger Receptors—HBA1—sarcoma	0.000832	0.00609	CbGpPWpGaD
Telaprevir—Urinary tract disorder—Etoposide—sarcoma	0.00083	0.00362	CcSEcCtD
Telaprevir—Candida infection—Doxorubicin—sarcoma	0.000829	0.00361	CcSEcCtD
Telaprevir—Infection—Thiotepa—sarcoma	0.000826	0.0036	CcSEcCtD
Telaprevir—Urethral disorder—Etoposide—sarcoma	0.000824	0.00359	CcSEcCtD
Telaprevir—Infection—Dactinomycin—sarcoma	0.00082	0.00357	CcSEcCtD
Telaprevir—Nervous system disorder—Thiotepa—sarcoma	0.000816	0.00355	CcSEcCtD
Telaprevir—CMA1—Signaling by SCF-KIT—MDM2—sarcoma	0.000815	0.00597	CbGpPWpGaD
Telaprevir—Thrombocytopenia—Thiotepa—sarcoma	0.000814	0.00355	CcSEcCtD
Telaprevir—Anaemia—Mitoxantrone—sarcoma	0.000813	0.00354	CcSEcCtD
Telaprevir—Thrombocytopenia—Dactinomycin—sarcoma	0.000808	0.00352	CcSEcCtD
Telaprevir—Skin disorder—Thiotepa—sarcoma	0.000808	0.00352	CcSEcCtD
Telaprevir—Erythema multiforme—Etoposide—sarcoma	0.000795	0.00346	CcSEcCtD
Telaprevir—CYP3A4—hematopoietic system—sarcoma	0.000793	0.00318	CbGeAlD
Telaprevir—Eye disorder—Etoposide—sarcoma	0.000786	0.00342	CcSEcCtD
Telaprevir—Eczema—Epirubicin—sarcoma	0.000758	0.0033	CcSEcCtD
Telaprevir—ORM1—lymph node—sarcoma	0.000755	0.00303	CbGeAlD
Telaprevir—CTSK—Adaptive Immune System—CD34—sarcoma	0.00075	0.0055	CbGpPWpGaD
Telaprevir—Renal failure acute—Epirubicin—sarcoma	0.000738	0.00321	CcSEcCtD
Telaprevir—Infection—Vincristine—sarcoma	0.000733	0.00319	CcSEcCtD
Telaprevir—CTSS—Toll-Like Receptors Cascades—CREB1—sarcoma	0.000723	0.0053	CbGpPWpGaD
Telaprevir—Nervous system disorder—Vincristine—sarcoma	0.000723	0.00315	CcSEcCtD
Telaprevir—Thrombocytopenia—Vincristine—sarcoma	0.000722	0.00314	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Thiotepa—sarcoma	0.000718	0.00313	CcSEcCtD
Telaprevir—Fatigue—Thiotepa—sarcoma	0.000717	0.00312	CcSEcCtD
Telaprevir—Dysgeusia—Etoposide—sarcoma	0.000717	0.00312	CcSEcCtD
Telaprevir—Infection—Mitoxantrone—sarcoma	0.000713	0.00311	CcSEcCtD
Telaprevir—Fatigue—Dactinomycin—sarcoma	0.000712	0.0031	CcSEcCtD
Telaprevir—Shock—Mitoxantrone—sarcoma	0.000707	0.00308	CcSEcCtD
Telaprevir—Thrombocytopenia—Mitoxantrone—sarcoma	0.000703	0.00306	CcSEcCtD
Telaprevir—Eczema—Doxorubicin—sarcoma	0.000701	0.00306	CcSEcCtD
Telaprevir—ALB—Vitamin B12 Metabolism—HBA1—sarcoma	0.000699	0.00512	CbGpPWpGaD
Telaprevir—Skin disorder—Mitoxantrone—sarcoma	0.000698	0.00304	CcSEcCtD
Telaprevir—Renal failure acute—Doxorubicin—sarcoma	0.000683	0.00297	CcSEcCtD
Telaprevir—CMA1—Extracellular matrix organization—KDR—sarcoma	0.000681	0.00498	CbGpPWpGaD
Telaprevir—Anaemia—Etoposide—sarcoma	0.000677	0.00295	CcSEcCtD
Telaprevir—ALB—lymph node—sarcoma	0.000662	0.00266	CbGeAlD
Telaprevir—Urticaria—Thiotepa—sarcoma	0.000661	0.00288	CcSEcCtD
Telaprevir—ABCB1—myometrium—sarcoma	0.000654	0.00262	CbGeAlD
Telaprevir—Loss of consciousness—Etoposide—sarcoma	0.000643	0.0028	CcSEcCtD
Telaprevir—Blood creatinine increased—Epirubicin—sarcoma	0.000638	0.00278	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Vincristine—sarcoma	0.000637	0.00277	CcSEcCtD
Telaprevir—Fatigue—Vincristine—sarcoma	0.000636	0.00277	CcSEcCtD
Telaprevir—CMA1—Signaling by SCF-KIT—SRC—sarcoma	0.000636	0.00466	CbGpPWpGaD
Telaprevir—CTSK—Toll-Like Receptors Cascades—JUN—sarcoma	0.000632	0.00463	CbGpPWpGaD
Telaprevir—ABCB1—embryo—sarcoma	0.000629	0.00252	CbGeAlD
Telaprevir—Hypokalaemia—Epirubicin—sarcoma	0.00062	0.0027	CcSEcCtD
Telaprevir—Fatigue—Mitoxantrone—sarcoma	0.000619	0.0027	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000619	0.0027	CcSEcCtD
Telaprevir—CTSS—Adaptive Immune System—CD34—sarcoma	0.000618	0.00453	CbGpPWpGaD
Telaprevir—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.000614	0.00267	CcSEcCtD
Telaprevir—CMA1—Signaling by SCF-KIT—NRAS—sarcoma	0.000612	0.00448	CbGpPWpGaD
Telaprevir—CTSK—Extracellular matrix organization—KDR—sarcoma	0.000607	0.00444	CbGpPWpGaD
Telaprevir—Asthenia—Thiotepa—sarcoma	0.000597	0.0026	CcSEcCtD
Telaprevir—Infection—Etoposide—sarcoma	0.000593	0.00258	CcSEcCtD
Telaprevir—Asthenia—Dactinomycin—sarcoma	0.000592	0.00258	CcSEcCtD
Telaprevir—ABCB1—seminal vesicle—sarcoma	0.000591	0.00237	CbGeAlD
Telaprevir—Blood creatinine increased—Doxorubicin—sarcoma	0.000591	0.00257	CcSEcCtD
Telaprevir—Pruritus—Thiotepa—sarcoma	0.000588	0.00256	CcSEcCtD
Telaprevir—Thrombocytopenia—Etoposide—sarcoma	0.000585	0.00255	CcSEcCtD
Telaprevir—Eosinophilia—Epirubicin—sarcoma	0.000583	0.00254	CcSEcCtD
Telaprevir—Skin disorder—Etoposide—sarcoma	0.00058	0.00253	CcSEcCtD
Telaprevir—ABCB1—HIF-1-alpha transcription factor network—NPM1—sarcoma	0.000579	0.00424	CbGpPWpGaD
Telaprevir—Hypokalaemia—Doxorubicin—sarcoma	0.000574	0.0025	CcSEcCtD
Telaprevir—Urticaria—Mitoxantrone—sarcoma	0.000571	0.00248	CcSEcCtD
Telaprevir—Diarrhoea—Thiotepa—sarcoma	0.000569	0.00248	CcSEcCtD
Telaprevir—ALB—Folate Metabolism—HBA1—sarcoma	0.000568	0.00416	CbGpPWpGaD
Telaprevir—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.000568	0.00247	CcSEcCtD
Telaprevir—Diarrhoea—Dactinomycin—sarcoma	0.000565	0.00246	CcSEcCtD
Telaprevir—ABCB1—hematopoietic system—sarcoma	0.000562	0.00225	CbGeAlD
Telaprevir—CMA1—Signaling by SCF-KIT—EGFR—sarcoma	0.000557	0.00408	CbGpPWpGaD
Telaprevir—CMA1—Extracellular matrix organization—MMP2—sarcoma	0.000556	0.00407	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—PLCG1—sarcoma	0.000553	0.00405	CbGpPWpGaD
Telaprevir—Dizziness—Thiotepa—sarcoma	0.00055	0.0024	CcSEcCtD
Telaprevir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—sarcoma	0.000549	0.00402	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—PTPRC—sarcoma	0.000543	0.00397	CbGpPWpGaD
Telaprevir—Eosinophilia—Doxorubicin—sarcoma	0.000539	0.00235	CcSEcCtD
Telaprevir—ABCB1—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000538	0.00394	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—PLCG1—sarcoma	0.000531	0.00389	CbGpPWpGaD
Telaprevir—ALB—Platelet degranulation—VEGFC—sarcoma	0.00053	0.00388	CbGpPWpGaD
Telaprevir—Asthenia—Vincristine—sarcoma	0.000529	0.0023	CcSEcCtD
Telaprevir—Vomiting—Thiotepa—sarcoma	0.000529	0.0023	CcSEcCtD
Telaprevir—CMA1—Signaling by SCF-KIT—KRAS—sarcoma	0.000526	0.00386	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—ATF1—sarcoma	0.000525	0.00385	CbGpPWpGaD
Telaprevir—Infestation NOS—Epirubicin—sarcoma	0.000525	0.00229	CcSEcCtD
Telaprevir—Infestation—Epirubicin—sarcoma	0.000525	0.00229	CcSEcCtD
Telaprevir—Vomiting—Dactinomycin—sarcoma	0.000525	0.00229	CcSEcCtD
Telaprevir—Rash—Thiotepa—sarcoma	0.000524	0.00228	CcSEcCtD
Telaprevir—Dermatitis—Thiotepa—sarcoma	0.000524	0.00228	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000521	0.00227	CcSEcCtD
Telaprevir—Rash—Dactinomycin—sarcoma	0.00052	0.00227	CcSEcCtD
Telaprevir—CTSS—Toll-Like Receptors Cascades—JUN—sarcoma	0.00052	0.00381	CbGpPWpGaD
Telaprevir—Gastrointestinal disorder—Etoposide—sarcoma	0.000516	0.00225	CcSEcCtD
Telaprevir—Asthenia—Mitoxantrone—sarcoma	0.000515	0.00224	CcSEcCtD
Telaprevir—Fatigue—Etoposide—sarcoma	0.000515	0.00224	CcSEcCtD
Telaprevir—Diarrhoea—Vincristine—sarcoma	0.000505	0.0022	CcSEcCtD
Telaprevir—ALB—Response to elevated platelet cytosolic Ca2+—VEGFC—sarcoma	0.000504	0.0037	CbGpPWpGaD
Telaprevir—CTSS—Extracellular matrix organization—KDR—sarcoma	0.0005	0.00366	CbGpPWpGaD
Telaprevir—Hepatobiliary disease—Epirubicin—sarcoma	0.000497	0.00216	CcSEcCtD
Telaprevir—CTSK—Extracellular matrix organization—MMP2—sarcoma	0.000495	0.00363	CbGpPWpGaD
Telaprevir—Nausea—Thiotepa—sarcoma	0.000494	0.00215	CcSEcCtD
Telaprevir—Diarrhoea—Mitoxantrone—sarcoma	0.000491	0.00214	CcSEcCtD
Telaprevir—Nausea—Dactinomycin—sarcoma	0.00049	0.00214	CcSEcCtD
Telaprevir—Dizziness—Vincristine—sarcoma	0.000488	0.00212	CcSEcCtD
Telaprevir—Infestation NOS—Doxorubicin—sarcoma	0.000486	0.00212	CcSEcCtD
Telaprevir—Infestation—Doxorubicin—sarcoma	0.000486	0.00212	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000482	0.0021	CcSEcCtD
Telaprevir—Urticaria—Etoposide—sarcoma	0.000475	0.00207	CcSEcCtD
Telaprevir—Vomiting—Vincristine—sarcoma	0.000469	0.00204	CcSEcCtD
Telaprevir—Urinary tract disorder—Epirubicin—sarcoma	0.000465	0.00203	CcSEcCtD
Telaprevir—Rash—Vincristine—sarcoma	0.000465	0.00203	CcSEcCtD
Telaprevir—Dermatitis—Vincristine—sarcoma	0.000465	0.00202	CcSEcCtD
Telaprevir—Oedema peripheral—Epirubicin—sarcoma	0.000464	0.00202	CcSEcCtD
Telaprevir—Urethral disorder—Epirubicin—sarcoma	0.000462	0.00201	CcSEcCtD
Telaprevir—Hepatobiliary disease—Doxorubicin—sarcoma	0.000459	0.002	CcSEcCtD
Telaprevir—Vomiting—Mitoxantrone—sarcoma	0.000457	0.00199	CcSEcCtD
Telaprevir—CTSS—Innate Immune System—PLCG1—sarcoma	0.000455	0.00334	CbGpPWpGaD
Telaprevir—CTSK—Immune System—CD34—sarcoma	0.000455	0.00333	CbGpPWpGaD
Telaprevir—Rash—Mitoxantrone—sarcoma	0.000453	0.00197	CcSEcCtD
Telaprevir—Dermatitis—Mitoxantrone—sarcoma	0.000452	0.00197	CcSEcCtD
Telaprevir—ALB—Selenium Micronutrient Network—HBA1—sarcoma	0.000452	0.00331	CbGpPWpGaD
Telaprevir—CMA1—Signaling by SCF-KIT—HRAS—sarcoma	0.000447	0.00328	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—PTPRC—sarcoma	0.000447	0.00327	CbGpPWpGaD
Telaprevir—Erythema multiforme—Epirubicin—sarcoma	0.000446	0.00194	CcSEcCtD
Telaprevir—Eye disorder—Epirubicin—sarcoma	0.00044	0.00192	CcSEcCtD
Telaprevir—Nausea—Vincristine—sarcoma	0.000438	0.00191	CcSEcCtD
Telaprevir—CTSS—Adaptive Immune System—PLCG1—sarcoma	0.000437	0.0032	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—ATF1—sarcoma	0.000433	0.00317	CbGpPWpGaD
Telaprevir—Urinary tract disorder—Doxorubicin—sarcoma	0.000431	0.00188	CcSEcCtD
Telaprevir—Oedema peripheral—Doxorubicin—sarcoma	0.00043	0.00187	CcSEcCtD
Telaprevir—Asthenia—Etoposide—sarcoma	0.000429	0.00187	CcSEcCtD
Telaprevir—Urethral disorder—Doxorubicin—sarcoma	0.000428	0.00186	CcSEcCtD
Telaprevir—Nausea—Mitoxantrone—sarcoma	0.000427	0.00186	CcSEcCtD
Telaprevir—ABCB1—uterus—sarcoma	0.000424	0.0017	CbGeAlD
Telaprevir—Pruritus—Etoposide—sarcoma	0.000423	0.00184	CcSEcCtD
Telaprevir—Erythema multiforme—Doxorubicin—sarcoma	0.000412	0.0018	CcSEcCtD
Telaprevir—CYP3A4—liver—sarcoma	0.000411	0.00165	CbGeAlD
Telaprevir—Malnutrition—Epirubicin—sarcoma	0.00041	0.00179	CcSEcCtD
Telaprevir—Diarrhoea—Etoposide—sarcoma	0.000409	0.00178	CcSEcCtD
Telaprevir—ABCB1—HIF-1-alpha transcription factor network—CXCR4—sarcoma	0.000409	0.00299	CbGpPWpGaD
Telaprevir—CTSS—Extracellular matrix organization—MMP2—sarcoma	0.000408	0.00299	CbGpPWpGaD
Telaprevir—Eye disorder—Doxorubicin—sarcoma	0.000408	0.00178	CcSEcCtD
Telaprevir—Dysgeusia—Epirubicin—sarcoma	0.000402	0.00175	CcSEcCtD
Telaprevir—ABCB1—lymphoid tissue—sarcoma	0.000395	0.00159	CbGeAlD
Telaprevir—Dizziness—Etoposide—sarcoma	0.000395	0.00172	CcSEcCtD
Telaprevir—CTSK—Innate Immune System—FOXO1—sarcoma	0.000392	0.00287	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—PDGFRB—sarcoma	0.000392	0.00287	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—PDGFRA—sarcoma	0.000386	0.00282	CbGpPWpGaD
Telaprevir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRB—sarcoma	0.000382	0.0028	CbGpPWpGaD
Telaprevir—Vomiting—Etoposide—sarcoma	0.00038	0.00165	CcSEcCtD
Telaprevir—Malnutrition—Doxorubicin—sarcoma	0.00038	0.00165	CcSEcCtD
Telaprevir—Anaemia—Epirubicin—sarcoma	0.000379	0.00165	CcSEcCtD
Telaprevir—CTSK—Adaptive Immune System—FOXO1—sarcoma	0.000377	0.00276	CbGpPWpGaD
Telaprevir—Rash—Etoposide—sarcoma	0.000377	0.00164	CcSEcCtD
Telaprevir—Dermatitis—Etoposide—sarcoma	0.000376	0.00164	CcSEcCtD
Telaprevir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—sarcoma	0.000376	0.00276	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—PDGFRB—sarcoma	0.000376	0.00275	CbGpPWpGaD
Telaprevir—CTSS—Immune System—CD34—sarcoma	0.000375	0.00275	CbGpPWpGaD
Telaprevir—Dysgeusia—Doxorubicin—sarcoma	0.000372	0.00162	CcSEcCtD
Telaprevir—CTSK—Adaptive Immune System—PDGFRA—sarcoma	0.00037	0.00271	CbGpPWpGaD
Telaprevir—Syncope—Epirubicin—sarcoma	0.000368	0.0016	CcSEcCtD
Telaprevir—Loss of consciousness—Epirubicin—sarcoma	0.000361	0.00157	CcSEcCtD
Telaprevir—ABCB1—bone marrow—sarcoma	0.00036	0.00144	CbGeAlD
Telaprevir—Nausea—Etoposide—sarcoma	0.000355	0.00155	CcSEcCtD
Telaprevir—CMA1—Signaling Pathways—TLE1—sarcoma	0.000352	0.00258	CbGpPWpGaD
Telaprevir—Anaemia—Doxorubicin—sarcoma	0.000351	0.00153	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000347	0.00151	CcSEcCtD
Telaprevir—ALB—FOXA2 and FOXA3 transcription factor networks—CREB1—sarcoma	0.000345	0.00253	CbGpPWpGaD
Telaprevir—Syncope—Doxorubicin—sarcoma	0.00034	0.00148	CcSEcCtD
Telaprevir—Loss of consciousness—Doxorubicin—sarcoma	0.000334	0.00145	CcSEcCtD
Telaprevir—Infection—Epirubicin—sarcoma	0.000333	0.00145	CcSEcCtD
Telaprevir—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000332	0.00243	CbGpPWpGaD
Telaprevir—Shock—Epirubicin—sarcoma	0.000329	0.00143	CcSEcCtD
Telaprevir—CTSK—Immune System—PTPRC—sarcoma	0.000329	0.00241	CbGpPWpGaD
Telaprevir—Nervous system disorder—Epirubicin—sarcoma	0.000328	0.00143	CcSEcCtD
Telaprevir—Thrombocytopenia—Epirubicin—sarcoma	0.000328	0.00143	CcSEcCtD
Telaprevir—Skin disorder—Epirubicin—sarcoma	0.000325	0.00142	CcSEcCtD
Telaprevir—CTSS—Innate Immune System—FOXO1—sarcoma	0.000323	0.00237	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—PDGFRB—sarcoma	0.000322	0.00236	CbGpPWpGaD
Telaprevir—CTSK—Immune System—PLCG1—sarcoma	0.000322	0.00236	CbGpPWpGaD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000321	0.0014	CcSEcCtD
Telaprevir—CTSS—Innate Immune System—PDGFRA—sarcoma	0.000317	0.00233	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—FOXO1—sarcoma	0.00031	0.00227	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—PDGFRB—sarcoma	0.00031	0.00227	CbGpPWpGaD
Telaprevir—Infection—Doxorubicin—sarcoma	0.000308	0.00134	CcSEcCtD
Telaprevir—ABCB1—testis—sarcoma	0.000308	0.00123	CbGeAlD
Telaprevir—CTSK—Immune System—ATF1—sarcoma	0.000306	0.00224	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—PDGFRA—sarcoma	0.000305	0.00223	CbGpPWpGaD
Telaprevir—Shock—Doxorubicin—sarcoma	0.000305	0.00133	CcSEcCtD
Telaprevir—Nervous system disorder—Doxorubicin—sarcoma	0.000304	0.00132	CcSEcCtD
Telaprevir—Thrombocytopenia—Doxorubicin—sarcoma	0.000303	0.00132	CcSEcCtD
Telaprevir—Skin disorder—Doxorubicin—sarcoma	0.000301	0.00131	CcSEcCtD
Telaprevir—CTSK—Innate Immune System—KIT—sarcoma	0.000299	0.00219	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—VEGFC—sarcoma	0.000297	0.00218	CbGpPWpGaD
Telaprevir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—sarcoma	0.000292	0.00214	CbGpPWpGaD
Telaprevir—ABCB1—liver—sarcoma	0.000291	0.00117	CbGeAlD
Telaprevir—Gastrointestinal disorder—Epirubicin—sarcoma	0.000289	0.00126	CcSEcCtD
Telaprevir—Fatigue—Epirubicin—sarcoma	0.000289	0.00126	CcSEcCtD
Telaprevir—CTSK—Adaptive Immune System—KIT—sarcoma	0.000287	0.0021	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—CREB1—sarcoma	0.000285	0.00208	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—CREB1—sarcoma	0.000273	0.002	CbGpPWpGaD
Telaprevir—CTSS—Immune System—PTPRC—sarcoma	0.000271	0.00198	CbGpPWpGaD
Telaprevir—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000267	0.00117	CcSEcCtD
Telaprevir—Fatigue—Doxorubicin—sarcoma	0.000267	0.00116	CcSEcCtD
Telaprevir—Urticaria—Epirubicin—sarcoma	0.000266	0.00116	CcSEcCtD
Telaprevir—CTSS—Immune System—PLCG1—sarcoma	0.000265	0.00194	CbGpPWpGaD
Telaprevir—CMA1—Metabolism of proteins—MMP2—sarcoma	0.00026	0.0019	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—PDGFRA—sarcoma	0.000257	0.00188	CbGpPWpGaD
Telaprevir—CTSS—Immune System—ATF1—sarcoma	0.000252	0.00185	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—KIT—sarcoma	0.000246	0.0018	CbGpPWpGaD
Telaprevir—Urticaria—Doxorubicin—sarcoma	0.000246	0.00107	CcSEcCtD
Telaprevir—Asthenia—Epirubicin—sarcoma	0.00024	0.00105	CcSEcCtD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	0.000239	0.00175	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—FLT1—sarcoma	0.000238	0.00174	CbGpPWpGaD
Telaprevir—Pruritus—Epirubicin—sarcoma	0.000237	0.00103	CcSEcCtD
Telaprevir—CTSS—Adaptive Immune System—KIT—sarcoma	0.000236	0.00173	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—MDM2—sarcoma	0.000235	0.00172	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—VEGFC—sarcoma	0.000235	0.00172	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—CREB1—sarcoma	0.000234	0.00172	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—PLCG1—sarcoma	0.000234	0.00171	CbGpPWpGaD
Telaprevir—Diarrhoea—Epirubicin—sarcoma	0.000229	0.000998	CcSEcCtD
Telaprevir—CTSK—Immune System—FOXO1—sarcoma	0.000229	0.00167	CbGpPWpGaD
Telaprevir—CTSK—Immune System—PDGFRB—sarcoma	0.000228	0.00167	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—MDM2—sarcoma	0.000226	0.00166	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—CREB1—sarcoma	0.000225	0.00165	CbGpPWpGaD
Telaprevir—CTSK—Immune System—PDGFRA—sarcoma	0.000225	0.00164	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CXCR4—sarcoma	0.000224	0.00164	CbGpPWpGaD
Telaprevir—ABCB1—lymph node—sarcoma	0.000223	0.000895	CbGeAlD
Telaprevir—Asthenia—Doxorubicin—sarcoma	0.000222	0.000968	CcSEcCtD
Telaprevir—CMA1—Signaling Pathways—ATF1—sarcoma	0.000222	0.00163	CbGpPWpGaD
Telaprevir—Dizziness—Epirubicin—sarcoma	0.000221	0.000964	CcSEcCtD
Telaprevir—Pruritus—Doxorubicin—sarcoma	0.000219	0.000955	CcSEcCtD
Telaprevir—ABCB1—HIF-1-alpha transcription factor network—CREB1—sarcoma	0.000219	0.0016	CbGpPWpGaD
Telaprevir—Vomiting—Epirubicin—sarcoma	0.000213	0.000927	CcSEcCtD
Telaprevir—Diarrhoea—Doxorubicin—sarcoma	0.000212	0.000923	CcSEcCtD
Telaprevir—Rash—Epirubicin—sarcoma	0.000211	0.00092	CcSEcCtD
Telaprevir—Dermatitis—Epirubicin—sarcoma	0.000211	0.000919	CcSEcCtD
Telaprevir—Dizziness—Doxorubicin—sarcoma	0.000205	0.000892	CcSEcCtD
Telaprevir—CTSK—Innate Immune System—JUN—sarcoma	0.000205	0.0015	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—CTNNB1—sarcoma	0.000203	0.00149	CbGpPWpGaD
Telaprevir—CMA1—Metabolism of proteins—CTNNB1—sarcoma	0.000199	0.00146	CbGpPWpGaD
Telaprevir—Nausea—Epirubicin—sarcoma	0.000199	0.000866	CcSEcCtD
Telaprevir—Vomiting—Doxorubicin—sarcoma	0.000197	0.000858	CcSEcCtD
Telaprevir—Rash—Doxorubicin—sarcoma	0.000195	0.000851	CcSEcCtD
Telaprevir—Dermatitis—Doxorubicin—sarcoma	0.000195	0.00085	CcSEcCtD
Telaprevir—CTSS—Innate Immune System—MDM2—sarcoma	0.000194	0.00142	CbGpPWpGaD
Telaprevir—CTSS—Immune System—FOXO1—sarcoma	0.000188	0.00138	CbGpPWpGaD
Telaprevir—CTSS—Immune System—PDGFRB—sarcoma	0.000188	0.00138	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—MDM2—sarcoma	0.000186	0.00136	CbGpPWpGaD
Telaprevir—CTSS—Immune System—PDGFRA—sarcoma	0.000185	0.00135	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—IL2—sarcoma	0.000185	0.00135	CbGpPWpGaD
Telaprevir—Nausea—Doxorubicin—sarcoma	0.000184	0.000802	CcSEcCtD
Telaprevir—CTSK—Innate Immune System—SRC—sarcoma	0.000184	0.00134	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—NRAS—sarcoma	0.000177	0.00129	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—SRC—sarcoma	0.000176	0.00129	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—IGF1R—sarcoma	0.000174	0.00128	CbGpPWpGaD
Telaprevir—CTSK—Immune System—KIT—sarcoma	0.000174	0.00128	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—NRAS—sarcoma	0.00017	0.00124	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—JUN—sarcoma	0.000169	0.00123	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—CTNNB1—sarcoma	0.000167	0.00122	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—FOXO1—sarcoma	0.000166	0.00121	CbGpPWpGaD
Telaprevir—CTSK—Immune System—CREB1—sarcoma	0.000166	0.00121	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—PDGFRB—sarcoma	0.000165	0.00121	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—TEK—sarcoma	0.000165	0.00121	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—PDGFRA—sarcoma	0.000163	0.00119	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—EGFR—sarcoma	0.000161	0.00118	CbGpPWpGaD
Telaprevir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—sarcoma	0.000161	0.00118	CbGpPWpGaD
Telaprevir—ABCB1—HIF-1-alpha transcription factor network—JUN—sarcoma	0.000157	0.00115	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—EGFR—sarcoma	0.000154	0.00113	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—KRAS—sarcoma	0.000152	0.00111	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—SRC—sarcoma	0.000151	0.00111	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—ANGPT2—sarcoma	0.000151	0.00111	CbGpPWpGaD
Telaprevir—CYP3A4—Tryptophan metabolism—MDM2—sarcoma	0.000149	0.00109	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—KRAS—sarcoma	0.000146	0.00107	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—NRAS—sarcoma	0.000145	0.00107	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—SRC—sarcoma	0.000145	0.00106	CbGpPWpGaD
Telaprevir—CTSS—Immune System—KIT—sarcoma	0.000143	0.00105	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—IL2—sarcoma	0.00014	0.00103	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—NRAS—sarcoma	0.00014	0.00102	CbGpPWpGaD
Telaprevir—ABCB1—HIF-1-alpha transcription factor network—VEGFA—sarcoma	0.000137	0.00101	CbGpPWpGaD
Telaprevir—CTSK—Immune System—MDM2—sarcoma	0.000137	0.001	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—KDR—sarcoma	0.000137	0.001	CbGpPWpGaD
Telaprevir—CTSS—Immune System—CREB1—sarcoma	0.000136	0.001	CbGpPWpGaD
Telaprevir—ALB—Platelet degranulation—VEGFA—sarcoma	0.000135	0.000985	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—EGFR—sarcoma	0.000132	0.00097	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—HRAS—sarcoma	0.000129	0.000946	CbGpPWpGaD
Telaprevir—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—sarcoma	0.000128	0.000939	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—EGFR—sarcoma	0.000127	0.000932	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	0.000127	0.000928	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—KIT—sarcoma	0.000126	0.000925	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—KRAS—sarcoma	0.000125	0.000917	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—HRAS—sarcoma	0.000124	0.000909	CbGpPWpGaD
Telaprevir—CTSK—Immune System—IL2—sarcoma	0.000123	0.000897	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—VEGFC—sarcoma	0.000121	0.000887	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CREB1—sarcoma	0.00012	0.000881	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—KRAS—sarcoma	0.00012	0.00088	CbGpPWpGaD
Telaprevir—CTSK—Immune System—JUN—sarcoma	0.000119	0.000873	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—VEGFA—sarcoma	0.000119	0.000872	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—TP53—sarcoma	0.000119	0.000869	CbGpPWpGaD
Telaprevir—CTSK—Immune System—CTNNB1—sarcoma	0.000118	0.000866	CbGpPWpGaD
Telaprevir—CTSS—Immune System—MDM2—sarcoma	0.000113	0.000827	CbGpPWpGaD
Telaprevir—CTSK—Immune System—SRC—sarcoma	0.000107	0.000783	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—HRAS—sarcoma	0.000106	0.000779	CbGpPWpGaD
Telaprevir—CTSK—Immune System—NRAS—sarcoma	0.000103	0.000753	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—HRAS—sarcoma	0.000102	0.000748	CbGpPWpGaD
Telaprevir—CTSS—Immune System—IL2—sarcoma	0.000101	0.000739	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—MDM2—sarcoma	9.95e-05	0.000729	CbGpPWpGaD
Telaprevir—CTSS—Immune System—JUN—sarcoma	9.81e-05	0.000719	CbGpPWpGaD
Telaprevir—CTSS—Immune System—CTNNB1—sarcoma	9.74e-05	0.000713	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—PLCG1—sarcoma	9.51e-05	0.000697	CbGpPWpGaD
Telaprevir—CTSK—Immune System—EGFR—sarcoma	9.37e-05	0.000686	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	9.35e-05	0.000685	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—IL2—sarcoma	8.89e-05	0.000651	CbGpPWpGaD
Telaprevir—CTSK—Immune System—KRAS—sarcoma	8.85e-05	0.000648	CbGpPWpGaD
Telaprevir—CTSS—Immune System—SRC—sarcoma	8.8e-05	0.000645	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CCND1—sarcoma	8.66e-05	0.000635	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—JUN—sarcoma	8.65e-05	0.000633	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CTNNB1—sarcoma	8.58e-05	0.000628	CbGpPWpGaD
Telaprevir—CTSS—Immune System—NRAS—sarcoma	8.47e-05	0.00062	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—SRC—sarcoma	7.76e-05	0.000568	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	7.74e-05	0.000567	CbGpPWpGaD
Telaprevir—CTSS—Immune System—EGFR—sarcoma	7.72e-05	0.000565	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—VEGFA—sarcoma	7.55e-05	0.000553	CbGpPWpGaD
Telaprevir—CTSK—Immune System—HRAS—sarcoma	7.52e-05	0.000551	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—NRAS—sarcoma	7.46e-05	0.000546	CbGpPWpGaD
Telaprevir—CTSS—Immune System—KRAS—sarcoma	7.29e-05	0.000534	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—IL2—sarcoma	7.02e-05	0.000514	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—MYC—sarcoma	6.95e-05	0.000509	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—EGFR—sarcoma	6.8e-05	0.000498	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	6.74e-05	0.000494	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	6.73e-05	0.000493	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	6.68e-05	0.000489	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—KRAS—sarcoma	6.42e-05	0.00047	CbGpPWpGaD
Telaprevir—CTSS—Immune System—HRAS—sarcoma	6.2e-05	0.000454	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—SRC—sarcoma	6.13e-05	0.000449	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	6.03e-05	0.000442	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—VEGFA—sarcoma	5.97e-05	0.000437	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	5.88e-05	0.00043	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—TP53—sarcoma	5.71e-05	0.000418	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—HRAS—sarcoma	5.46e-05	0.0004	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	5.41e-05	0.000396	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	5.29e-05	0.000387	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	5e-05	0.000366	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ENO2—sarcoma	4.55e-05	0.000333	CbGpPWpGaD
Telaprevir—ALB—Metabolism—HBA1—sarcoma	4.52e-05	0.000331	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	4.44e-05	0.000325	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ENO2—sarcoma	3.98e-05	0.000292	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—HBA1—sarcoma	3.96e-05	0.00029	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PLCG1—sarcoma	3.86e-05	0.000283	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—IL2—sarcoma	3.62e-05	0.000265	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PLCG1—sarcoma	3.38e-05	0.000248	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—SRC—sarcoma	3.16e-05	0.000231	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—VEGFA—sarcoma	3.08e-05	0.000225	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—NRAS—sarcoma	3.04e-05	0.000223	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—KRAS—sarcoma	2.62e-05	0.000192	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ENO2—sarcoma	2.45e-05	0.00018	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—HBA1—sarcoma	2.44e-05	0.000179	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—TP53—sarcoma	2.32e-05	0.00017	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—HRAS—sarcoma	2.22e-05	0.000163	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PLCG1—sarcoma	2.08e-05	0.000153	CbGpPWpGaD
